查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930070

全球伤口闭合市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Wound Closure Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 请询问到货日

价格

伤口闭合市场成长因子

2025年全球伤口闭合市场价值为151亿美元。受外科手术数量增加和慢性病患病率上升的推动，预计该市场将在2026年达到160.9亿美元，并在2034年达到283.4亿美元。北美地区在伤口闭合市场中占据领先地位，2025年市场占有率为37.80%，这得益于其先进的医院基础设施、高额的医疗保健支出以及创新外科产品的快速普及。

伤口闭合利用缝线、缝合钉、止血剂和黏合剂等技术促进组织癒合和预防感染，在急救和外科手术中发挥着非常重要的作用。心血管、骨科、妇科和一般外科手术量的增加，显着推动了医疗机构对高效伤口管理解决方案的需求。

市场驱动因素与成长因素

心血管疾病、骨科疾病、关节炎和糖尿病等慢性疾病的增加，导致全球住院率和手术干预率上升。老化人口尤其容易患上这些疾病，导致需要可靠伤口闭合产品的手术数量增加。

创伤病例和意外伤害的增加也促进了手术需求的成长。高效的伤口闭合系统对于骨折、内出血和组织损伤的紧急治疗非常重要，这持续推动创伤中心和外科部门对这类产品的应用。

抗菌缝线、可吸收聚合物和生物活性止血剂等伤口闭合材料的创新，有助于改善癒合效果并减少手术部位感染。这些临床优势正促使医院和门诊手术中心以先进的伤口闭合解决方案取代传统材料。

市场限制因素与成本障碍

儘管临床需求强劲，但先进伤口闭合器械的高昂成本仍然是一个重要的限制因素，尤其是在新兴经济体。电动手术缝合器、专用止血钳和涂层缝线的生产成本和监管合规成本都很高，导致最终用户价格高昂。

此外，一些中低收入国家的保险覆盖范围限制进一步限制了手术的可及性，并限制了产品的供应。病患和医院层面的经济限制都会影响采购决策，尤其是对于价格较高的伤口闭合技术。

市场机会与监管支持

FDA 和 EMA 等监管机构的严格标准为成功获得产品批准的製造商创造了机会。由于符合先进临床要求的伤口闭合技术有限，因此投资于临床试验和安全性验证的公司将获得竞争优势。

新型止血剂、缝线和手术吻合器的持续监管审批加速创新医疗器材的市场准入。人们对感染预防、手术安全和缩短恢復时间的日益关注，推动了多个外科专科对新一代伤口管理产品的需求。

市场挑战

产品召回仍然是製造商面临的一项重大营运挑战。与器械故障、药筒损坏、污染和标籤错误相关的召回会对医院的信任度和监管监督产生负面影响。这些事件会扰乱供应链，增加合规成本，并给在该市场营运的公司带来声誉风险。

确保稳定的生产品质并进行上市后监测对于维持长期的市场信任和监管合规非常重要。

市场趋势

伤口闭合市场的一个显着趋势是从传统方法转向先进的伤口闭合解决方案。外科医师日益采用生物可吸收缝线、抗菌涂层和水胶体密封剂来促进组织癒合并降低感染风险。与传统缝合技术相比，这些产品能够提供更高的精确度和更稳定的临床效果。

另一个主要趋势是微创手术（MIS）的需求不断成长。微创手术中产生的小切口需要使用专门的伤口闭合装置，以促进快速癒合并最大程度地减少疤痕。在人们对更短恢復时间和更短住院时间的需求不断成长的推动下，用于腹腔镜和机器人手术的先进缝合系统正迅速普及。

市场区隔分析

依产品类型

依产品类型划分，市场可分为缝合线、止血钳、缝合器和其他。预计到2026年，缝线将以39.45%的市场占有率引领市场，这主要得益于其在几乎所有外科手术中的广泛应用，以及可吸收和抗菌材料的持续创新。止血剂占据第二大市场占有率，这主要归功于其在控制术中出血方面日益重要的作用。在手术量大的环境中，速度和一致性非常重要，因此缝合器的使用率持续成长。

依应用领域划分

依应用领域划分，市场占有率涵盖一般外科、心臟外科、骨科、妇产科、眼科及其他领域。到2026年，一般外科市场将占据最大的市场占有率，达到22.62%，这主要得益于阑尾切除术、疝气修补术和胆囊手术数量的成长。心臟外科市场预计将因心臟手术的增加而快速成长。同时，骨科市场也受益于关节置换和创伤手术的增加。

依最终使用者划分

依最终使用者划分，市场可分为医院/门诊手术中心、专科诊所及其他机构。医院和门诊手术中心预计将占据市场主导地位，到2026年将占据 69.90%的市场占有率，这主要得益于较高的住院量、先进的手术基础设施以及更完善的医保覆盖。专科诊所，尤其是在城市地区，持续扩张，提供高强度的外科手术服务，并缩短患者等待时间。

区域展望

到2025年，北美市场规模达到 57.1亿美元，这主要得益于较高的手术率、强大的保险覆盖以及产品的快速普及。预计到2026年，美国市场规模将达到 55.9亿美元，主要得益于慢性病盛行率的上升和持续的产品创新。

预计欧洲市场将因慢性病盛行率的上升以及政府为减少手术部位感染所采取的措施而成长。预计到2026年，英国市场规模将达到 9.7亿美元，德国市场规模将达到 8.4亿美元。

亚太地区正经历显着成长，这主要得益于庞大的患者群体和不断成长的医疗保健投资。预计到2026年，中国市场规模将达到 9.8亿美元，日本将达到 8.6亿美元，印度将达到 6.8亿美元，这得益于不断扩大的外科手术能力和新医疗器材的监管审批。

拉丁美洲、中东和非洲预计将出现温和成长，这主要得益于医院基础设施的改善以及公共医疗保健系统对外科手术认识的提高。

竞争格局与产业趋势

伤口闭合市场的主要企业包括Johnson & Johnson Services, Inc.、Baxter、Medtronic、B. Braun SE、Stryker、Smith+Nephew、Boston Scientific Corporation、CooperSurgical、Genesis Medtech。这些公司正积极投资于产品发布、监管审批、全球扩张以及参与医学会议，以增强品牌知名度和临床应用。

近期行业趋势包括机器人手术系统、先进的缝合钉平台、可吸收止血剂和创新缝合材料的获批，所有这些都目的是提高手术精度和患者安全。持续的研发投入和监管审批增强其在已开发和新兴医疗市场的竞争优势。

分析范围

全球伤口闭合市场报告全面分析了市场规模、产品细分、应用需求、终端用户采纳、区域表现、竞争策略和技术进步。本报告评估了将在2025年、2026年和2034年影响市场成长的医疗趋势、手术量、监管框架和产品创新模式，为全球外科医疗器材行业的製造商、医疗服务提供者、分销商和投资者提供策略见解。

缝合线、缝合器和止血钳等技术的进步有助于提高手术精准度、降低感染风险并加快患者康復，推动了这些产品在医院和门诊手术中心（ASC）的应用。缝线市场占有率预计在2026年将达到 39.45%，而医院和门诊手术中心（ASC）的市场占有率高达 69.90%，这表明市场成长将继续依赖手术量大的环境。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 各国及地区主要手术数（2025年）
  • 主要公司新产品发布
  • 伤口闭合市场的技术进步
  • 主要产业趋势：併购、业务合作等

第5章 全球伤口闭合市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 缝合线
      • 可吸收缝合线
      • 不可吸收缝合线
    • 止血剂
      • 主动止血剂
      • 被动止血剂
      • 复方止血剂
      • 其他
    • 缝合器
      • 电动
      • 手动
    • 其他
  • 市场分析、洞察与预测：依用途与适应症划分
    • 骨科
    • 妇产科
    • 其他外科手术
    • 眼科
    • 心臟科
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院及门诊手术中心
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美伤口闭合市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲伤口闭合市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太地区伤口闭合市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲伤口闭合市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲伤口闭合市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • GCC国家
    • 南非
    • 中东其他地区非洲

第11章 竞争分析

  • 全球市场占有率分析（2025年）
  • 公司简介
    • Johnson &Johnson Services, Inc.
    • Baxter
    • Medtronic
    • Artivion, Inc.
    • Stryker
    • 3M
    • CP Medical（Riverpoint Medical）
    • Boston Scientific Corporation
    • Smith+Nephew
    • B. Braun SE
    • MANI, INC.
    • CONMED Corporation
    • Genesis Medtech
    • CooperSurgical Inc.
    • Intuitive Surgical
    • Frankenman International Ltd.
Product Code: FBI102630

Growth Factors of wound closure Market

The global wound closure market size was valued at USD 15.10 billion in 2025. The market is projected to grow to USD 16.09 billion in 2026 and further reach USD 28.34 billion by 2034, reflecting strong expansion driven by rising surgical volumes and growing prevalence of chronic diseases. North America dominated the wound closure market with a 37.80% market share in 2025, supported by advanced hospital infrastructure, high healthcare spending, and rapid adoption of innovative surgical products.

Wound closure plays a critical role in emergency medicine and surgical procedures, involving techniques such as sutures, staplers, hemostatic agents, and adhesives used to promote tissue healing and prevent infections. Increasing numbers of cardiovascular, orthopedic, gynecological, and general surgeries are significantly increasing demand for effective wound management solutions across healthcare facilities.

Market Drivers and Growth Factors

The growing burden of chronic diseases such as cardiovascular disorders, orthopedic conditions, arthritis, and diabetes is increasing hospitalization rates and surgical interventions globally. A large portion of aging populations is particularly vulnerable to these conditions, leading to higher procedural volumes that require reliable wound closure products.

The rising number of trauma cases and accident-related injuries also contributes to increased surgical demand. Emergency procedures for fractures, internal bleeding, and tissue injuries rely heavily on efficient wound closure systems, which is driving consistent product utilization across trauma centers and surgical departments.

Technological innovation in wound closure materials, including antibacterial sutures, absorbable polymers, and bioactive hemostats, is improving healing outcomes and reducing surgical site infections. These clinical benefits are encouraging hospitals and ambulatory surgical centers to replace conventional materials with advanced wound closure solutions.

Market Restraints and Cost Barriers

Despite strong clinical demand, the high cost of advanced wound closure devices remains a major restraint, particularly in emerging economies. Powered surgical staplers, specialized hemostatic agents, and coated sutures involve high manufacturing and regulatory compliance costs, resulting in expensive end-user pricing.

Limited reimbursement coverage in several low- and middle-income countries further restricts access to surgical procedures, thereby limiting product utilization. Financial constraints at both patient and hospital levels affect procurement decisions, particularly for premium wound closure technologies.

Market Opportunities and Regulatory Support

Stringent regulatory standards imposed by agencies such as the FDA and EMA are creating opportunities for manufacturers that successfully achieve product approvals. As only a limited number of wound closure technologies meet advanced clinical requirements, companies investing in clinical trials and safety validation are gaining competitive advantages.

Ongoing regulatory approvals for new hemostats, sutures, and surgical staplers are accelerating market entry of innovative devices. Increased focus on infection prevention, surgical safety, and faster recovery outcomes is expanding demand for next-generation wound management products across multiple surgical specialties.

Market Challenges

Product recalls remain a critical operational challenge for manufacturers. Recalls related to device malfunctions, cartridge damage, contamination, and labeling errors negatively affect hospital trust and regulatory scrutiny. Such incidents disrupt supply chains, increase compliance costs, and create reputational risks for companies operating in this market.

Ensuring consistent manufacturing quality and post-market surveillance remains essential for sustaining long-term market confidence and regulatory compliance.

Market Trends

A significant trend in the wound closure market is the shift from traditional methods to advanced wound closure solutions. Surgeons are increasingly adopting bioresorbable sutures, antibacterial-coated materials, and hydrocolloid-based sealants that enhance tissue healing and reduce infection risks. These products offer better precision and consistent clinical outcomes compared to conventional closure techniques.

Another major trend is the rising preference for minimally invasive surgeries (MIS). Smaller incisions created during MIS procedures require specialized wound closure devices that promote rapid healing with minimal scarring. As demand for faster recovery and shorter hospital stays increases, advanced closure systems compatible with laparoscopic and robotic surgeries are witnessing strong adoption.

Segmentation Analysis

By Product Type

The market is segmented into sutures, hemostatic agents, staplers, and others. The sutures segment dominated the market with a 39.45% share in 2026, driven by widespread use across nearly all surgical procedures and continuous innovation in absorbable and antibacterial materials. Hemostatic agents hold the second-largest share due to their growing role in controlling intraoperative bleeding. Staplers continue to gain adoption in high-volume surgical environments where speed and consistency are critical.

By Application

Based on application, the market includes general surgery, cardiology, orthopedics, gynecology and obstetrics, ophthalmology, and others. The general surgery segment held the largest share at 22.62% in 2026, supported by high volumes of appendectomies, hernia repairs, and gallbladder surgeries. Cardiology is expected to grow rapidly due to increasing cardiac procedures, while orthopedics benefits from rising joint replacement and trauma surgeries.

By End User

The market is segmented into hospitals & ambulatory surgical centers, specialty clinics, and others. The hospitals & ASCs segment dominated with a 69.90% share in 2026, driven by high inpatient surgical volumes, access to advanced surgical infrastructure, and stronger reimbursement coverage. Specialty clinics continue to expand, particularly in urban regions, offering focused surgical services with shorter patient turnaround times.

Regional Outlook

North America recorded a market value of USD 5.71 billion in 2025, supported by high surgical rates, strong insurance coverage, and rapid product adoption. The U.S. market is projected to reach USD 5.59 billion by 2026 due to growing chronic disease prevalence and continuous product innovation.

Europe is experiencing growth driven by increasing chronic disease incidence and government initiatives to reduce surgical site infections. The UK market is projected to reach USD 0.97 billion by 2026, while Germany is projected to reach USD 0.84 billion by 2026.

Asia Pacific is witnessing strong expansion due to large patient populations and rising healthcare investments. By 2026, China is projected to reach USD 0.98 billion, Japan USD 0.86 billion, and India USD 0.68 billion, supported by expanding surgical capacity and regulatory approvals for new devices.

Latin America and the Middle East & Africa are experiencing gradual growth driven by improving hospital infrastructure and rising surgical awareness across public healthcare systems.

Competitive Landscape and Industry Developments

Key companies operating in the wound closure market include Johnson & Johnson Services, Inc., Baxter, Medtronic, B. Braun SE, Stryker, Smith+Nephew, Boston Scientific Corporation, CooperSurgical, and Genesis Medtech. These companies are actively investing in product launches, regulatory approvals, global expansion, and medical conference participation to strengthen brand visibility and clinical adoption.

Recent industry developments include approvals for robotic surgical systems, advanced stapling platforms, absorbable hemostatic agents, and innovative suture materials aimed at improving surgical precision and patient safety. Continuous R&D investments and regulatory clearances are strengthening competitive positioning across both developed and emerging healthcare markets.

Report Coverage

The wound closure market report provides comprehensive analysis of market size, product segmentation, application-based demand, end-user adoption, regional performance, competitive strategies, and technological advancements. The report evaluates healthcare trends, surgical procedure volumes, regulatory frameworks, and product innovation patterns shaping market growth between 2025, 2026, and 2034, offering strategic insights for manufacturers, healthcare providers, distributors, and investors operating within the global surgical device industry.

Conclusion

The wound closure market is showing strong and consistent expansion, with the global market valued at USD 15.10 billion in 2025, projected to reach USD 16.09 billion in 2026, and expected to grow further to USD 28.34 billion by 2034. This growth is primarily driven by the rising number of surgical procedures associated with chronic diseases, trauma cases, and age-related medical conditions, which are increasing the demand for reliable and efficient wound management solutions across healthcare systems.

Technological advancements in sutures, staplers, and hemostatic agents are improving surgical precision, reducing infection risks, and supporting faster patient recovery, which is strengthening adoption across hospitals and ambulatory surgical centers. The dominance of the sutures segment with a 39.45% share in 2026 and the strong presence of hospitals & ASCs with a 69.90% share in 2026 highlight the continued reliance on high-volume surgical environments for market growth.

Segmentation By Product Type

  • Sutures
    • Absorbable
    • Non-Absorbable
  • Hemostatic Agents
    • Active Hemostats
    • Passive Hemostats
    • Combination Hemostats
    • Others
  • Staplers
    • Powered
    • Manual
  • Others

By Application

  • Orthopedics
  • Gynecology and Obstetrics
  • General Surgery
  • Ophthalmology
  • Cardiology
  • Others

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Procedures, by Key Countries/Region, 2025
  • 4.2. New Product Launches - by Key Players
  • 4.3. Technological Advancements in Wound Closure Market
  • 4.4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)

5. Global Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Sutures
      • 5.1.1.1. Absorbable
      • 5.1.1.2. Non-absorbable
    • 5.1.2. Hemostatic Agents
      • 5.1.2.1. Active Hemostats
      • 5.1.2.2. Passive Hemostats
      • 5.1.2.3. Combination Hemostats
      • 5.1.2.4. Others
    • 5.1.3. Staplers
      • 5.1.3.1. Powered
      • 5.1.3.2. Manual
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Orthopedics
    • 5.2.2. Gynecology and Obstetrics
    • 5.2.3. General Surgery
    • 5.2.4. Ophthalmology
    • 5.2.5. Cardiology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Sutures
      • 6.1.1.1. Absorbable
      • 6.1.1.2. Non-absorbable
    • 6.1.2. Hemostatic Agents
      • 6.1.2.1. Active Hemostats
      • 6.1.2.2. Passive Hemostats
      • 6.1.2.3. Combination Hemostats
      • 6.1.2.4. Others
    • 6.1.3. Staplers
      • 6.1.3.1. Powered
      • 6.1.3.2. Manual
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Orthopedics
    • 6.2.2. Gynecology and Obstetrics
    • 6.2.3. General Surgery
    • 6.2.4. Ophthalmology
    • 6.2.5. Cardiology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Sutures
      • 7.1.1.1. Absorbable
      • 7.1.1.2. Non-absorbable
    • 7.1.2. Hemostatic Agents
      • 7.1.2.1. Active Hemostats
      • 7.1.2.2. Passive Hemostats
      • 7.1.2.3. Combination Hemostats
      • 7.1.2.4. Others
    • 7.1.3. Staplers
      • 7.1.3.1. Powered
      • 7.1.3.2. Manual
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Orthopedics
    • 7.2.2. Gynecology and Obstetrics
    • 7.2.3. General Surgery
    • 7.2.4. Ophthalmology
    • 7.2.5. Cardiology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Sutures
      • 8.1.1.1. Absorbable
      • 8.1.1.2. Non-absorbable
    • 8.1.2. Hemostatic Agents
      • 8.1.2.1. Active Hemostats
      • 8.1.2.2. Passive Hemostats
      • 8.1.2.3. Combination Hemostats
      • 8.1.2.4. Others
    • 8.1.3. Staplers
      • 8.1.3.1. Powered
      • 8.1.3.2. Manual
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Orthopedics
    • 8.2.2. Gynecology and Obstetrics
    • 8.2.3. General Surgery
    • 8.2.4. Ophthalmology
    • 8.2.5. Cardiology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Sutures
      • 9.1.1.1. Absorbable
      • 9.1.1.2. Non-absorbable
    • 9.1.2. Hemostatic Agents
      • 9.1.2.1. Active Hemostats
      • 9.1.2.2. Passive Hemostats
      • 9.1.2.3. Combination Hemostats
      • 9.1.2.4. Others
    • 9.1.3. Staplers
      • 9.1.3.1. Powered
      • 9.1.3.2. Manual
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Orthopedics
    • 9.2.2. Gynecology and Obstetrics
    • 9.2.3. General Surgery
    • 9.2.4. Ophthalmology
    • 9.2.5. Cardiology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Sutures
      • 10.1.1.1. Absorbable
      • 10.1.1.2. Non-absorbable
    • 10.1.2. Hemostatic Agents
      • 10.1.2.1. Active Hemostats
      • 10.1.2.2. Passive Hemostats
      • 10.1.2.3. Combination Hemostats
      • 10.1.2.4. Others
    • 10.1.3. Staplers
      • 10.1.3.1. Powered
      • 10.1.3.2. Manual
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Orthopedics
    • 10.2.2. Gynecology and Obstetrics
    • 10.2.3. General Surgery
    • 10.2.4. Ophthalmology
    • 10.2.5. Cardiology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Baxter
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Artivion, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Stryker
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. 3M
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. CP Medical (Riverpoint Medical)
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Boston Scientific Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Smith+Nephew
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. B. Braun SE
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. MANI, INC.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. CONMED Corporation
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)
    • 11.2.13. Genesis Medtech
      • 11.2.13.1. Overview
      • 11.2.13.2. Products
      • 11.2.13.3. SWOT Analysis
      • 11.2.13.4. Recent Developments
      • 11.2.13.5. Strategies
      • 11.2.13.6. Financials (Based on Availability)
    • 11.2.14. CooperSurgical Inc.
      • 11.2.14.1. Overview
      • 11.2.14.2. Products
      • 11.2.14.3. SWOT Analysis
      • 11.2.14.4. Recent Developments
      • 11.2.14.5. Strategies
      • 11.2.14.6. Financials (Based on Availability)
    • 11.2.15. Intuitive Surgical
      • 11.2.15.1. Overview
      • 11.2.15.2. Products
      • 11.2.15.3. SWOT Analysis
      • 11.2.15.4. Recent Developments
      • 11.2.15.5. Strategies
      • 11.2.15.6. Financials (Based on Availability)
    • 11.2.16. Frankenman International Ltd.
      • 11.2.16.1. Overview
      • 11.2.16.2. Products
      • 11.2.16.3. SWOT Analysis
      • 11.2.16.4. Recent Developments
      • 11.2.16.5. Strategies
      • 11.2.16.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 3: Global Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 4: Global Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 5: Global Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Wound Closure Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 9: North America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 10: North America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 11: North America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 12: North America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Wound Closure Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Europe Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 17: Europe Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 18: Europe Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 19: Europe Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 24: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 25: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 26: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 31: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 32: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 33: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 38: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 39: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 40: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Wound Closure Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Wound Closure Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Wound Closure Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Wound Closure Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Wound Closure Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 10: North America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 12: North America Wound Closure Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Wound Closure Market Value Share (%), By Country, 2025
  • Figure 14: Europe Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Wound Closure Market Value Share (%), by Application, 2025
  • Figure 18: Europe Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Wound Closure Market Value Share (%), by End User, 2025
  • Figure 20: Europe Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Wound Closure Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Wound Closure Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Wound Closure Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Wound Closure Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Wound Closure Market Share (%), By Company, 2025
  • Figure 47: Global Staplers Market Share (%), By Company, 2025